TransMedics to Report Second Quarter 2025 Financial Results on July 30, 2025
TransMedics (NASDAQ: TMDX), a medical technology company focused on organ transplant therapy, has scheduled its Second Quarter 2025 financial results announcement for July 30, 2025, after market close.
The company will host a conference call at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results. Investors can join via phone using specific dial-in numbers or access the webcast through TransMedics' investor relations website.
TransMedics (NASDAQ: TMDX), un'azienda di tecnologia medica specializzata nella terapia del trapianto di organi, ha programmato l'annuncio dei risultati finanziari del secondo trimestre 2025 per il 30 luglio 2025, dopo la chiusura del mercato.
L'azienda terrà una conference call alle 16:30 ET / 13:30 PT per discutere i risultati. Gli investitori potranno partecipare telefonicamente utilizzando numeri di accesso specifici o seguire la trasmissione web tramite il sito web delle relazioni con gli investitori di TransMedics.
TransMedics (NASDAQ: TMDX), una empresa de tecnología médica enfocada en la terapia de trasplante de órganos, ha programado el anuncio de resultados financieros del segundo trimestre de 2025 para el 30 de julio de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia a las 4:30 p.m. ET / 1:30 p.m. PT para discutir los resultados. Los inversores pueden unirse por teléfono usando números específicos o acceder a la transmisión web a través del sitio web de relaciones con inversores de TransMedics.
TransMedics (NASDAQ: TMDX)는 장기 이식 치료에 중점을 둔 의료 기술 회사로, 2025년 7월 30일 2분기 2025년 재무 실적 발표를 시장 마감 후에 예정했습니다.
회사는 동부 표준시 오후 4시 30분 / 태평양 표준시 오후 1시 30분에 컨퍼런스 콜을 개최하여 실적을 논의할 예정입니다. 투자자들은 특정 전화 번호를 통해 참여하거나 TransMedics 투자자 관계 웹사이트를 통해 웹캐스트에 접속할 수 있습니다.
TransMedics (NASDAQ : TMDX), une société de technologie médicale spécialisée dans la thérapie de transplantation d'organes, a prévu l'annonce des résultats financiers du deuxième trimestre 2025 pour le 30 juillet 2025, après la clôture du marché.
La société organisera une conférence téléphonique à 16h30 ET / 13h30 PT pour discuter des résultats. Les investisseurs peuvent participer par téléphone en utilisant des numéros d'appel spécifiques ou accéder au webinaire via le site des relations investisseurs de TransMedics.
TransMedics (NASDAQ: TMDX), ein Medizintechnikunternehmen mit Schwerpunkt auf Organtransplantationstherapie, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für den 30. Juli 2025 nach Börsenschluss angesetzt.
Das Unternehmen wird um 16:30 Uhr ET / 13:30 Uhr PT eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können per Telefon über spezifische Einwahlnummern teilnehmen oder den Webcast über die Investor-Relations-Website von TransMedics verfolgen.
- None.
- None.
Investors interested in listening to the conference call may do so by dialing (844) 676-6010 for domestic callers or (412) 634-6944 for international callers and ask to be joined into the TransMedics call. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-second-quarter-2025-financial-results-on-july-30-2025-302506922.html
SOURCE TransMedics Group, Inc.
FAQ
When will TransMedics (TMDX) release Q2 2025 earnings?
What time is the TransMedics Q2 2025 earnings call?
How can investors join the TransMedics Q2 2025 earnings call?
Where can I access the webcast of TransMedics Q2 2025 earnings call?
